DR

Dharmesh Rameshbhai Vaghasiya

Active Director Partner DIN 09537913
DIN 09537913 First appointment Mar 2018 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 8 active board seats
Past companies –
Total affiliations 8 Since Mar 2018
Shareholding value •••• Premium profile

About Dharmesh Rameshbhai Vaghasiya

Data last updated:

Dharmesh Rameshbhai Vaghasiya has 8 years in corporate governance. Holds Partner and Director roles. Currently with 8 companies, including Surat Institute Of Medical Science Llp and Sugujin Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹17.01 Cr; the largest is Sorus Laboratories (India) Private Limited at ₹15.46 Cr (FY 2025).

DIN 09537913
Primary Designation Partner
First Appointment 21 Mar 2018
Oldest Company Age 8 yrs
Largest company Sorus Laboratories (India) Private Limited · ₹15.46 Cr (FY 2025)
Combined revenue ₹17.01 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Mar 20252023₹15.46 Cr (FY 2025)Active
Shc Healthcare Private Limited U85300GJ2022PTC130171
Director17 Mar 20222022₹1.50 Cr (FY 2025)Active
Sugujin Private Limited U70109GJ2022PTC130150
Director16 Mar 20222022₹5.1 Lakh (FY 2024)Active
Designated Partner16 Jul 20252025–Active
Sugujin Diagnostics Private Limited U46596GJ2024PTC155823
Director17 Oct 20242024–Active
Bci Healthcare Private Limited U86100GJ2023PTC143918
Director18 Aug 20232023–Active
Partner14 Feb 20232023–Active
Partner21 Mar 20182018–Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Surat Institute Of Medical Science Llp
Sugujin Private Limited
Shc Healthcare Private Limited
Sorus Laboratories Llp
Premium access

Shareholding and investment profile for Dharmesh Rameshbhai Vaghasiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dharmesh Rameshbhai Vaghasiya

Dharmesh Rameshbhai Vaghasiya has 8 years in corporate governance. Holds Partner and Director roles. Currently with 8 companies, including Surat Institute Of Medical Science Llp and Sugujin Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹17.01 Cr; the largest is Sorus Laboratories (India) Private Limited at ₹15.46 Cr (FY 2025).

Dharmesh Rameshbhai Vaghasiya is associated with 8 companies as Partner and Director, including Sorus Laboratories (India) Private Limited (₹15.46 Cr), Shc Healthcare Private Limited (₹1.50 Cr), Sugujin Private Limited (₹5.1 Lakh).

Dharmesh Rameshbhai Vaghasiya has expertise in General Business, Healthcare.

Dharmesh Rameshbhai Vaghasiya has 8 years in corporate governance.

By reported revenue, the largest current company of Dharmesh Rameshbhai Vaghasiya is Sorus Laboratories (India) Private Limited, with revenue of ₹15.46 Cr (FY 2025).

The 3 current companies of Dharmesh Rameshbhai Vaghasiya that report revenue have a combined latest revenue of ₹17.01 Cr.

Dharmesh Rameshbhai Vaghasiya currently holds positions at 8 companies; the 5 largest by reported revenue are Sorus Laboratories (India) Private Limited (₹15.46 Cr), Shc Healthcare Private Limited (₹1.50 Cr), Sugujin Private Limited (₹5.1 Lakh), Sorus Laboratories Saurashtra Llp, Sugujin Diagnostics Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available